MRK Jan 2025 180.000 call
OPR - OPR Delayed price. Currency in USD
Add to watchlist
As of 02:43PM EDT. Market open.
| Previous close | 0.2600 |
| Open | 0.1700 |
| Bid | 0.0000 |
| Ask | 0.0000 |
| Strike | 180.00 |
| Expiry date | 2025-01-17 |
| Day's range | 0.1700 - 0.2600 |
| Contract range | N/A |
| Volume | |
| Open interest | N/A |
ZacksInvestors Heavily Search Merck & Co., Inc. (MRK): Here is What You Need to Know
Recently, Zacks.com users have been paying close attention to Merck (MRK). This makes it worthwhile to examine what the stock has in store.
Business WireMerck Provides Update on Phase 3 KEYNOTE-B21 Trial Evaluating KEYTRUDA® (pembrolizumab) Plus Chemotherapy, With or Without Radiotherapy, for Patients With Newly Diagnosed, High-Risk Endometrial Cancer After Surgery With Curative Intent
RAHWAY, N.J., May 09, 2024--Merck Provides Update on Phase 3 KEYNOTE-B21 Trial
- Thomson Reuters StreetEvents
Q1 2024 OPKO Health Inc Earnings Call
Q1 2024 OPKO Health Inc Earnings Call
© 2024 Yahoo. All rights reserved.